Common Contracts

AGREEMENT AND PLAN OF MERGER among ADVAXIS, INC., AYALA PHARMACEUTICALS, INC. and DOE MERGER SUB, INC. Dated as of October 18, 2022

Merger Agreement • October 19th, 2022 • Ayala Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Merger Agreement
• Filed
  October 19th, 2022
• Company
  Ayala Pharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of October 18, 2022, among Ayala Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Advaxis, Inc., a Delaware corporation (“Parent”), and Doe Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”). Parent, Merger Sub and the Company are each sometimes referred to herein as a “Party” and collectively as the “Parties”.

AGREEMENT AND PLAN OF MERGER among: AQUINOX PHARMACEUTICALS, INC., a Delaware corporation; APOLLO SUB, INC., a Delaware corporation; and NEOLEUKIN THERAPEUTICS, INC., a Delaware corporation Dated as of August 5, 2019

Merger Agreement • August 6th, 2019 • Aquinox Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Merger Agreement
• Filed
  August 6th, 2019
• Company
  Aquinox Pharmaceuticals, Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of August 5, 2019, by and among AQUINOX PHARMACEUTICALS, INC., a Delaware corporation (“Parent”), APOLLO SUB, INC., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and NEOLEUKIN THERAPEUTICS, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.